Foam that stops bleeding from the inside: new trial underway

NCT ID NCT02880163

Recruiting now Disease control Sponsor: Arsenal Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests a device called ResQFoam, an expandable foam injected into the abdomen to stop severe internal bleeding caused by trauma. The study involves 40 people with life-threatening hemorrhagic shock who need emergency surgery. The goal is to see if the foam can safely raise blood pressure and control bleeding until surgery can be performed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ResQFoam (expandable foam device)
What this could lead to: If successful, this foam could quickly stop life-threatening abdominal bleeding in trauma patients, buying time for surgery and improving survival.
What could go wrong: This is an early study with only 40 participants, so results may not apply to all patients. The foam could cause complications like increased abdominal pressure or fail to control bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXSANGUINATING HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Exsanguination injury Shock, Hemorrhagic Shock, Traumatic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXSANGUINATING HEMORRHAGE HEMORRHAGIC SHOCK SHOCK, TRAUMATIC TRAUMA

Contacts and locations

Locations

University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35294, United States
University of Cincinnati
RECRUITING

Cincinnati, Ohio, 45219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.